I don't think the dilution will be looked down upon too much. I think people understand that this is a startup company and need to raise money through potentially dilutive means. The company couldn't have issued debt, because they don't have the cashflow to service it. The only options were the warrants and convertibles, which they used. The most important thing now is to see the doctor's feedback to the STATPATCH.